Vismodegib, a small-molecule inhibitor of the hedgehog pathway for the treatment of advanced cancers Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Tuesday, May 25, 2010

Vismodegib, a small-molecule inhibitor of the hedgehog pathway for the treatment of advanced cancers



"Vismodegib is currently undergoing phase II clinical trials for the treatment of advanced BCC, metastatic colorectal cancer, ovarian cancer, MB and other solid tumors. Because of its low toxicity and specificity for the Hh (hedgehog) pathway, this drug has potential advantages compared with conventional chemotherapy, and may also be used in combination treatments. Clinical trials with other Hh inhibitors are also ongoing and their therapeutic potential will need to be compared with vismodegib."

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.